ctrl K

Price Alert

CAMP4 Therapeutics Corpor... (CAMP)

NASDAQ: CAMP · Real-Time Price · USD

1.47

-0.08 (-5.16%)

At close: Aug 15, 2025, 1:10 PM

CAMP4 Therapeutics Income Statement

Financials in USD. Fiscal year is March - February.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Nov 30, 2023	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Revenue	652K	186.23M	294.95M	295.84M	308.59M
Cost of Revenue	n/a	119.25M	185.94M	173.95M	186.18M
Gross Profit	652K	66.98M	109.01M	121.89M	122.41M
Operating Income	-53.09M	-8.72M	-21.48M	-15.31M	-3.87M
Interest Income	1.33M	2.81M	n/a	n/a	n/a
Pretax Income	-51.79M	-92.74M	-31.34M	-30.06M	-20.6M
Net Income	-51.79M	-93.26M	-32.49M	-31.15M	-21.16M
Selling & General & Admin	14.92M	61.01M	99.21M	100.9M	95.28M
Research & Development	38.82M	14.69M	24.57M	28.44M	25.81M
Other Expenses	n/a	n/a	5.33M	5.42M	4.78M
Operating Expenses	53.74M	75.7M	129.11M	134.76M	125.87M
Interest Expense	n/a	n/a	6.26M	15.32M	15.49M
Selling & Marketing Expenses	n/a	29.52M	47.39M	48.56M	46.2M
Cost & Expenses	53.74M	194.95M	315.05M	308.71M	312.05M
Income Tax Expense	n/a	-525K	1.15M	1.09M	561K
Shares Outstanding (Basic)	19.51M	37.02M	36.1M	35.25M	34.12M
Shares Outstanding (Diluted)	19.51M	37.02M	36.13M	35.25M	34.39M
EPS (Basic)	-2.66	-2.52	-0.9	-0.88	-0.62
EPS (Diluted)	-2.66	-2.52	-0.9	-0.88	-0.62
EBITDA	-51.39M	-8.72M	276K	7.49M	18.13M
EBIT	-53.09M	n/a	-21.48M	-15.31M	-3.87M
Depreciation & Amortization	1.7M	n/a	21.76M	22.8M	22M